
KRAS
ProductHeard in 5 episodes across 5 shows since Aug 2026
KRAS is a signaling protein and cancer-related gene whose mutations can drive tumor growth; it is a therapeutic target in several cancers, including pancreatic cancer.
Episodes
This week
Expert statements
Share of the conversation
Mentions of KRAS per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 27 | 0.02‰ | 2 |
| Sep 1 | 0.03‰ | 1 |
| Oct 19 | 0.03‰ | 3 |
| Oct 30 | 0.02‰ | 2 |
Email alert
Email me when KRAS comes up on a podcast
One email a week at most, with the new episodes that mention KRAS. Free, no account needed, unsubscribe in one click.
What experts have said about KRAS
1 statement · 1 positive
Drug development has made KRAS a tractable therapeutic target.
“unlock this target KRAS that was once thought to be undruggable.”
Open the episode · 419: Assessing Merck and Moderna's mRNA cancer vaccineListen at 11:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
5 episodes featuring KRAS, newest first
- Oct 30, 2026
Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026 - Oct 19, 2026
Cancer prevention meets the unfinished science of agingThe Peter Attia DriveOct 19, 2026 - Sep 1, 2026
Flood disaster and cancer breakthrough frame AM UpdateThe Megyn Kelly ShowSep 1, 2026 - Aug 27, 2026
Floods, political scrutiny and Tim Curry’s film legacyThe 7Aug 27, 2026 - Aug 27, 2026
ICE arrests hit records as Meta faces child-safety settlementThe HeadlinesAug 27, 2026